Skip to main content
. 2012 Sep 4;12:736. doi: 10.1186/1471-2458-12-736

Table 1.

Model Inputs for the patient characteristics and cost

Input Value Sensitivity Range Source Data
Life Expectancy, in years
 
 
 
 
CD4 = 50-200
9.60
8.16
11.04
[19]
CD4 = 200-350
19.30
16.41
22.20
[19]
CD4 tests per year
2
 
 
[20]
Median CD4 cell decline, per 6 months
45.75
30.65
62.35
[21]
DALY Adjustmenta
 
 
 
 
HIV
0.123
 
 
[22]
AIDS
0.5
 
 
[22]
Years of AIDS before death
1
 
 
Assumption
Annual Number of Inpatient Days with OIb,c
 
 
 
 
CD4 > 350 (on cART)
0.37
0.19
0.56
[23]
CD4 > 350 (off cART)
5.7
2.85
8.55
[23]
CD4 = 201-350 (on cART)
0.52
0.26
0.78
[23]
CD4 = 201-350 (off cART)
10.8
5.4
16.2
[23]
Annual Number of Inpatient Days without OIb,c
 
 
 
 
CD4 > 350 (on cART)
0.14
0.07
0.21
[23]
CD4 > 350 (off cART)
1.9
0.95
2.85
[23]
CD4 = 201-350 (on cART)
0.39
0.2
0.59
[23]
CD4 = 201-350 (off cART)
3
1.5
4.5
[23]
Costs
 
 
 
 
cART drug cost, per yeard
$192.44
$100
$300
[24]
cART maintenance cost, year
$113.40
$50
$200
[25]
Total Treatment cost, sum
$305.84
$150
$500
[24,25]
Annual costs incurred while waiting
 
 
 
 
Clinic Personel
$14.32
 
 
[25]
Lab
$35.04
 
 
[25]
Other Medication
$33.72
 
 
[25]
Radiology
$1.68
 
 
[25]
Sum
$84.76
$0
$150
[25]
Cost per Inpatient Day
$31.48
 
 
[26]
Discount Rate 3% 0% 6% [18]

aDALY - Disability Adjusted Life Years.

b OI – Opportunistic infections.

c The sensitivity range is not reported in [23]. In our model, we assume a 50% decrease and 50% increase in OI’s relative to the base case.

dcART- combination antiretroviral therapy, containing: AZT – zidovudine ; 3TC – lamivudine; EFV- efavirenz.